Searched for
LIPITOR
Molecule glue drugs shake up cancer care, draw big moneyHarvard-born idea doubles survival in trials, triggers pharma frenzy as cos race to target 'undruggable' proteins with next-gen glue therap...- Ranbaxy can only sell US-made Lipitor copyThe US Food and Drug Administration has allowed Ranbaxy to manufacture generic Lipitor at Ohm Labs facility in the US for American market.
- Dr Reddy's launches Atorvastatin calcium tablets in USDr Reddy's said that it has launched Atorvastatin calcium tablets, a bioequivalent generic version of Lipitor tablets in the US.
- Five retailers led by Walgreen sue Pfizer, Ranbaxy for Lipitor generic delayFive big retailers led by Walgreen have sued Pfizer and Ranbaxy for allegedly delaying launch of the Indian company's low-cost version of L...
- Lipitor prescription dips 50%, boost for RanbaxyShare price of Ranbaxy Laboratories gained 3% after reports said that prescription of Pfizer’s cholesterol lowering drug Lipitor fell by 50...
- Ranbaxy set to get USFDA nod for Lipitor generic launch"The FDA has been very positive about Ranbaxy's intent to launch the product and we are working towards meeting the launch timeline", a per...
- Watson starts selling generic Lipitor in US, Ranbaxy mumUS-based Watson Pharmaceuticals said it has launched in US market the generic version of cholesterol lowering drug Lipitor following the ex...
- Ranbaxy struggling to get approvals for Lipitor; stock downShares of Ranbaxy were trading lower in early trade on Wednesday, following reports that the company is still struggling to get approvals f...
- Lipitor goes off patent today, Pfizer vs Ranbaxy-led Indian pharma's war for blockbuster drugs intensifiesBut for Indian companies, it was not always supposed to be like this. The end of Lipitor’s patent was meant to be a eureka moment for Ranba...
- Pfizer fights to retain Lipitor market shareThe move is expected to hit Ranbaxy Pharma, which has the exclusive rights to sell the generic version for three months beginning November ...
- Pfizer marketing may hit Ranbaxy’s profit from low-cost lipitor versionLate last year, Pfizer started offering ‘co-pay’ programmes which lowered out of pocket payment by insured patients to $4 a month for a Lip...
- Ranbaxy: Uncertainty over Lipitor keeps investors edgyWith resolution of FDA issues pending, it is also not clear whether Ranbaxy will be allowed to launch the Lipitor generic.
- Ranbaxy and Pfizer sued for delay in launch of Lipitor in USA group of US pharmacies filed lawsuit against Ranbaxy, Pfizer & accused the two drug firms of delaying the launch of Lipitor in the US
- Ranbaxy Laboratories to roll out Lipitor Clone in US on Nov 30Following a settlement in 2008, Pfizer Inc gave Ranbaxy exclusive marketing rights to sell Lipitor's low-cost version for six months.
- Pfizer, Dr Reddy's settle patent suit over LipitorPfizer's Lipitor is the world's largest-selling drug, which generated about $7 billion in sales last year in the US alone.
- Pfizer recalls more bottles of Lipitor over odorThe company has now recalled more than 360,000 bottles of Lipitor because of the odor issue, but said the latest recall will not result in ...
- Pfizer resuming ads for Lipitor after controversyTelevision ads for the world's top-selling drug, cholesterol fighter Lipitor, are back, six months after Pfizer Inc pulled them amid charge...
- Partial win for Ranbaxy in Lipitor caseIn a partial victory for Ranbaxy Laboratories in its patent litigation against Pfizer, an Australian court has ruled in the Indian company'...
- Pfizer again sues Ranbaxy over LipitorPfizer has filed two separate patent infringement cases against Ranbaxy in a bid to extend the exclusivity of its $13-billion anti-choleste...
- Ranbaxy's US launch of Lipitor drug only in 2010With the US Supreme Court rejecting an appeal by Ranbaxy to launch a generic drug of Lipitor in the US before its patent expires in 2010, R...
Load More
